Latest:
Will Ozempic fall out of fashion?
Popularity of Novo Nordisk’s “Magical” weight loss drug, Ozempic, has spread much like the pandemic since its approval as an obesity treatment in 2021. Are these wonder drugs set to dominate the future, or have we overlooked some red flags along the way?
Biotech Bulls: three skyrocketing stocks after earnings week
Eli Lilly’s antibody treatment for Alzheimer’s disease has shown to slow disease progression by 35% in Phase 3 trials! The 20 years of research that led to this breakthrough have provided key insights into tracking the progress and mechanisms of Alzheimer’s disease progression.